Detailed Information

Cited 9 time in webofscience Cited 9 time in scopus
Metadata Downloads

Asian Organization for Crohn's and Colitis and Asian Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment. Part 1: Risk assessmentopen access

Authors
Park, Dong I. I.Hisamatsu, TadakazuChen, MinhuNg, Siew ChienOoi, Choon JinWei, Shu ChenBanerjee, RupaHilmi, Ida NormihaJeen, Yoon TaeHan, Dong SooKim, Hyo JongRan, ZhihuaWu, KaichunQian, JiamingHu, Pin-JinMatsuoka, KatsuyoshiAndoh, AkiraSuzuki, YasuoSugano, KentaroWatanabe, MamoruHibi, ToshifumiPuri, Amarender S.Yang, Suk-Kyun
Issue Date
Jan-2018
Publisher
WILEY
Keywords
anti-TNF; consensus statement; inflammatory bowel disease; tuberculosis
Citation
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, v.33, no.1, pp.20 - 29
Indexed
SCIE
SCOPUS
Journal Title
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Volume
33
Number
1
Start Page
20
End Page
29
URI
https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/4016
DOI
10.1111/jgh.14019
ISSN
0815-9319
Abstract
Because anti-tumor necrosis factor (anti-TNF) therapy has become increasingly popular in many Asian countries, the risk of developing active tuberculosis (TB) among anti-TNF users may raise serious health problems in this region. Thus, the Asian Organization for Crohn's and Colitis and the Asian Pacific Association of Gastroenterology have developed a set of consensus statements about risk assessment, detection, and prevention of latent TB infection and management of active TB infection in patients with inflammatory bowel disease (IBD) receiving anti-TNF treatment. Twenty-three consensus statements were initially drafted and then discussed by the committee members. The quality of evidence and the strength of recommendations were assessed by using the Grading of Recommendations Assessment, Development, and Evaluation methodology. Web-based consensus voting was performed by 211 IBD specialists from nine Asian countries concerning each statement. A consensus statement was accepted if at least 75% of the participants agreed. Part 1 of the statements comprised two parts: (i) risk of TB infection during anti-TNF therapy and (ii) screening for TB infection prior to commencing anti-TNF therapy. These consensus statements will help clinicians optimize patient outcomes by reducing the morbidity and mortality related to TB infections in patients with IBD receiving anti-TNF treatment.
Files in This Item
There are no files associated with this item.
Appears in
Collections
2. Clinical Science > Department of Gastroenterology and Hepatology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Jeen, Yoon Tae photo

Jeen, Yoon Tae
Anam Hospital (Department of Gastroenterology and Hepatology, Anam Hospital)
Read more

Altmetrics

Total Views & Downloads

BROWSE